Detalhe da pesquisa
1.
Rapamycin nanoparticles increase the therapeutic window of engineered interleukin-2 and drive expansion of antigen-specific regulatory T cells for protection against autoimmune disease.
J Autoimmun
; 140: 103125, 2023 Oct 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37844543